{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T03:29:47Z","timestamp":1789442987036,"version":"build-2803163510"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.mce.2015.08.004","type":"journal-article","created":{"date-parts":[[2015,8,8]],"date-time":"2015-08-08T10:57:57Z","timestamp":1439031477000},"page":"60-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Animal models of spontaneous pancreatic neuroendocrine tumors"],"prefix":"10.1016","volume":"421","author":[{"given":"Run","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2015.08.004_bib1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/325223a0","article-title":"Non-tolerance and autoantibodies to a transgenic self antigen expressed in pancreatic beta cells","volume":"325","author":"Adams","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.mce.2015.08.004_bib2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1055\/s-2005-870139","article-title":"Menin molecular interactions: insights into normal functions and tumorigenesis","volume":"37","author":"Agarwal","year":"2005","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.mce.2015.08.004_bib3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.molonc.2012.01.006","article-title":"Heterogeneity among RIP-Tag2 insulinomas allows vascular endothelial growth factor-A independent tumor expansion as revealed by studies in Shb mutant mice: implications for tumor angiogenesis","volume":"6","author":"\u00c5kerblom","year":"2012","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.mce.2015.08.004_bib4","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1172\/JCI35237","article-title":"Constitutively active Akt1 expression in mouse pancreas requires S6 kinase 1 for insulinoma formation","volume":"118","author":"Alliouachene","year":"2008","journal-title":"J.\u00a0Clin. Invest."},{"issue":"2","key":"10.1016\/j.mce.2015.08.004_bib5","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/MPA.0b013e31825b6acd","article-title":"Glucagon cell adenomatosis without glucagon receptor mutation","volume":"42","author":"Al-Sarireh","year":"2013","journal-title":"Pancreas"},{"key":"10.1016\/j.mce.2015.08.004_bib6","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/BF00202891","article-title":"Development of colonic and pancreatic endocrine tumours in mice expressing a glucagon-SV40 T antigen transgene","volume":"427","author":"Asa","year":"1996","journal-title":"Virchows Arch."},{"key":"10.1016\/j.mce.2015.08.004_bib7","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/MPA.0b013e31827ae993","article-title":"Animal models and cell lines of pancreatic neuroendocrine tumors","volume":"42","author":"Babu","year":"2013","journal-title":"Pancreas"},{"key":"10.1016\/j.mce.2015.08.004_bib8","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1093\/carcin\/11.8.1393","article-title":"Hyperplasia and tumors of the islets of Langerhans in mice bearing an elastase I-SV40 T-antigen fusion gene","volume":"11","author":"Bell","year":"1990","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.mce.2015.08.004_bib9","first-page":"995","article-title":"Angiogenesis and apoptosis are cellular parameters of neoplastic progression in transgenic mouse models of tumorigenesis","volume":"42","author":"Bergers","year":"1998","journal-title":"Int. J. Dev. Biol."},{"key":"10.1016\/j.mce.2015.08.004_bib10","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0925-4773(03)00039-X","article-title":"Genetic ablation of the tumor suppressor menin causes lethality at mid-gestation with defects in multiple organs","volume":"120","author":"Bertolino","year":"2003","journal-title":"Mech. Dev."},{"key":"10.1016\/j.mce.2015.08.004_bib11","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1210\/me.2003-0154","article-title":"Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1","volume":"17","author":"Bertolino","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2015.08.004_bib12","first-page":"4836","article-title":"Pancreatic beta-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice","volume":"63","author":"Bertolino","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2015.08.004_bib13","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1128\/MCB.24.8.3125-3131.2004","article-title":"Conditional inactivation of the MEN1 gene leads to pancreatic and pituitary tumorigenesis but does not affect normal development of these tissues","volume":"24","author":"Biondi","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.mce.2015.08.004_bib14","doi-asserted-by":"crossref","first-page":"14723","DOI":"10.1073\/pnas.1303386110","article-title":"Retinoblastoma tumor suppressor protein in pancreatic progenitors controls \u03b1- and \u03b2-cell fate","volume":"110","author":"Cai","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mce.2015.08.004_bib15","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1038\/ncomms3810","article-title":"Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY1","volume":"4","author":"Cao","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mce.2015.08.004_bib16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ccr.2005.09.005","article-title":"Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors","volume":"8","author":"Casanovas","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.mce.2015.08.004_bib17","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1073\/pnas.98.3.1118","article-title":"A\u00a0mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors","volume":"98","author":"Crabtree","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mce.2015.08.004_bib18","doi-asserted-by":"crossref","first-page":"6075","DOI":"10.1128\/MCB.23.17.6075-6085.2003","article-title":"Of mice and MEN1: insulinomas in a conditional mouse knockout","volume":"23","author":"Crabtree","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.mce.2015.08.004_bib19","first-page":"401","article-title":"Metal-inducible pathology in the liver, pancreas, and kidney of transgenic mice expressing SV40 early region genes","volume":"135","author":"Dyer","year":"1989","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mce.2015.08.004_bib20","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0896-6273(88)90110-9","article-title":"Glucagon gene regulatory region directs oncoprotein expression to neurons and pancreatic alpha cells","volume":"1","author":"Efrat","year":"1988","journal-title":"Neuron"},{"key":"10.1016\/j.mce.2015.08.004_bib21","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/339058a0","article-title":"Induction of angiogenesis during the transition from hyperplasia to neoplasia","volume":"339","author":"Folkman","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.mce.2015.08.004_bib22","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1677\/erc.1.01294","article-title":"Gene expression profiling in insulinomas of Men1 beta-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic beta-cell tumorigenesis","volume":"13","author":"Fontani\u00e8re","year":"2006","journal-title":"Endocr. Relat. Cancer."},{"key":"10.1016\/j.mce.2015.08.004_bib23","doi-asserted-by":"crossref","first-page":"6646","DOI":"10.1073\/pnas.94.13.6646","article-title":"Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2","volume":"94","author":"Furuta","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.mce.2015.08.004_bib24","doi-asserted-by":"crossref","first-page":"5706","DOI":"10.1038\/onc.2013.514","article-title":"Conditional deletion of p53 and Rb in the renin-expressing compartment of the pancreas leads to a highly penetrant metastatic pancreatic neuroendocrine carcinoma","volume":"33","author":"Glenn","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.mce.2015.08.004_bib25","doi-asserted-by":"crossref","first-page":"9102","DOI":"10.1073\/pnas.94.17.9102","article-title":"Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice","volume":"94","author":"Gnarra","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mce.2015.08.004_bib26","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1515\/bc.2010.080","article-title":"Deletion of cathepsin H perturbs angiogenic switching, vascularization and growth of tumors in a mouse model of pancreatic islet cell cancer","volume":"391","author":"Gocheva","year":"2010","journal-title":"Biol. Chem."},{"key":"10.1016\/j.mce.2015.08.004_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/315115a0","article-title":"Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin\/simian virus 40 oncogenes","volume":"315","author":"Hanahan","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.mce.2015.08.004_bib28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0002-9440(10)65112-7","article-title":"Transgene expression and repression in transgenic rats bearing the phosphoenolpyruvate carboxykinase-simian virus 40 T antigen or the phosphoenolpyruvate carboxykinase-transforming growth factor-alpha constructs","volume":"155","author":"Haas","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mce.2015.08.004_bib29","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00006676-200003000-00015","article-title":"Multiple polypeptide hormone expression in pancreatic islet cell carcinomas derived from phosphoenolpyruvatecarboxykinase-SV40 T antigen transgenic rats","volume":"20","author":"Haas","year":"2000","journal-title":"Pancreas"},{"key":"10.1016\/j.mce.2015.08.004_bib30","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1210\/me.2009-0296","article-title":"Mice deficient for glucagon gene-derived peptides display normoglycemia and hyperplasia of islet\u00a0alpha cells but not of intestinal L-cells","volume":"23","author":"Hayashi","year":"2009","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2015.08.004_bib31","series-title":"Endocrine Society's 96th Annual Meeting and Expo, June 21\u201324","article-title":"Pancreatic neuroendocrine tumors in mice deficient in glucagon gene","author":"Hayashi","year":"2014"},{"key":"10.1016\/j.mce.2015.08.004_bib32","first-page":"384","article-title":"Transgenic hepatocarcinogenesis in the rat","volume":"145","author":"Hully","year":"1994","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mce.2015.08.004_bib33","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/cncr.23648","article-title":"Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies","volume":"113","author":"Jensen","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.mce.2015.08.004_bib34","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1126\/science.1200609","article-title":"DAXX\/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors","volume":"331","author":"Jiao","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.mce.2015.08.004_bib35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/iep.12066","article-title":"Islets of Langerhans from prohormone convertase-2 knockout mice show \u03b1-cell hyperplasia and tumorigenesis with elevated \u03b1-cell neogenesis","volume":"95","author":"Jones","year":"2014","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.mce.2015.08.004_bib36","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S1535-6108(03)00271-X","article-title":"Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis","volume":"4","author":"Joyce","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.mce.2015.08.004_bib37","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/BF01297144","article-title":"Clinical pathology of endocrine tumors of the pancreas. Analysis of autopsy cases","volume":"36","author":"Kimura","year":"1991","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.mce.2015.08.004_bib38","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s12022-007-0025-5","article-title":"Endocrine precursor lesions of gastroenteropancreatic neuroendocrine tumors","volume":"18","author":"Kloppel","year":"2007","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.mce.2015.08.004_bib39","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1200\/JCO.2008.19.2161","article-title":"Revisiting C.G. Moertel's land of small tumors","volume":"26","author":"Kvols","year":"2008","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.mce.2015.08.004_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ecl.2010.12.005","article-title":"The epidemiology of gastroenteropancreatic neuroendocrine tumors","volume":"40","author":"Lawrence","year":"2011","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.mce.2015.08.004_bib41","doi-asserted-by":"crossref","first-page":"10705","DOI":"10.1016\/S0021-9258(19)50075-8","article-title":"Glucagon gene 5'-flanking sequences direct expression of simian virus 40 large T antigen to the intestine, producing carcinoma of the large bowel in transgenic mice","volume":"267","author":"Lee","year":"1992","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mce.2015.08.004_bib42","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1053\/j.gastro.2010.01.046","article-title":"Alpha cell-specific Men1 ablation triggers the transdifferentiation of glucagon-expressing cells and insulinoma development","volume":"138","author":"Lu","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mce.2015.08.004_bib43","first-page":"84","article-title":"Mahvash disease: pancreatic neuroendocrine tumor syndrome caused by inactivating glucagon receptor mutation","volume":"7","author":"Lucas","year":"2013","journal-title":"J.\u00a0Mol. Genet. Med."},{"key":"10.1016\/j.mce.2015.08.004_bib44","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1172\/JCI58976","article-title":"Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice","volume":"122","author":"Maione","year":"2012","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.mce.2015.08.004_bib45","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1172\/JCI24612","article-title":"Rapid vascular regrowth in tumors after reversal of VEGF inhibition","volume":"116","author":"Mancuso","year":"2006","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.mce.2015.08.004_bib46","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/emboj\/20.4.672","article-title":"Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis","volume":"20","author":"Mandriota","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.mce.2015.08.004_bib47","first-page":"397","article-title":"Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias","volume":"54","author":"Marx","year":"1999","journal-title":"Recent Prog. Horm. Res."},{"key":"10.1016\/j.mce.2015.08.004_bib48","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1210\/endo-111-6-2091","article-title":"Stimulation of insulin release by glucose in a transplantable rat islet cell tumor","volume":"111","author":"Masiello","year":"1982","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2015.08.004_bib49","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/019262338401200311","article-title":"Streptozotocin-induced functioning islet cell tumor in the rat: high frequency of induction and biological properties of the tumor cells","volume":"12","author":"Masiello","year":"1984","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.mce.2015.08.004_bib50","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1053\/j.gastro.2008.05.047","article-title":"Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors","volume":"135","author":"Metz","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mce.2015.08.004_bib51","doi-asserted-by":"crossref","first-page":"6696","DOI":"10.1073\/pnas.90.14.6696","article-title":"Tumors in hepatobiliary tract and pancreatic islet tissues of transgenic mice harboring gastrin simian virus 40 large tumor antigen fusion gene","volume":"90","author":"Montag","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mce.2015.08.004_bib52","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/ijc.22734","article-title":"Global expression profiling of murine MEN1-associated tumors reveals a regulatory role for menin in transcription, cell cycle and chromatin remodelling","volume":"121","author":"Mould","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mce.2015.08.004_bib53","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.bpg.2005.06.002","article-title":"Endocrine tumours of the pancreas","volume":"19","author":"Oberg","year":"2005","journal-title":"Best. Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.mce.2015.08.004_bib54","doi-asserted-by":"crossref","first-page":"E2404","DOI":"10.1073\/pnas.1319962111","article-title":"PHLDA3 is a novel tumor suppressor of pancreatic neuroendocrine tumors","volume":"111","author":"Ohki","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mce.2015.08.004_bib55","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1159\/000212085","article-title":"A\u00a0fuller understanding of pancreatic neuroendocrine tumours combined with aggressive management improves outcome","volume":"9","author":"Ong","year":"2009","journal-title":"Pancreatology"},{"key":"10.1016\/j.mce.2015.08.004_bib56","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1172\/JCI118406","article-title":"Modulation of L-selectin ligand expression during an immune response accompanying tumorigenesis in transgenic mice","volume":"97","author":"Onrust","year":"1996","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.mce.2015.08.004_bib57","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3748\/wjg.v17.i2.137","article-title":"Pathologic pancreatic endocrine cell hyperplasia","volume":"17","author":"Ouyang","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.mce.2015.08.004_bib58","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ccr.2009.01.027","article-title":"Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis","volume":"15","author":"P\u00e0ez-Ribes","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.mce.2015.08.004_bib59","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1200\/JCO.2010.33.0688","article-title":"Metastatic and locally advanced pancreatic endocrine carcinomas: analysis of factors associated with disease progression","volume":"29","author":"Panzuto","year":"2011","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.mce.2015.08.004_bib60","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1006\/bbrc.2001.6265","article-title":"Glycemic control in mice with targeted disruption of the glucagon receptor gene","volume":"290","author":"Parker","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mce.2015.08.004_bib61","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0092-8674(02)00738-9","article-title":"Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression","volume":"109","author":"Pelengaris","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.mce.2015.08.004_bib62","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/gut.28.Suppl.121","article-title":"Transgenic mouse model: a new approach for the investigation of endocrine pancreatic B-cell growth","volume":"28","author":"Power","year":"1987","journal-title":"Gut"},{"key":"10.1016\/j.mce.2015.08.004_bib63","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1073\/pnas.061633698","article-title":"L-selectin can facilitate metastasis to lymph nodes in a transgenic mouse model of carcinogenesis","volume":"98","author":"Qian","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mce.2015.08.004_bib64","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF01600225","article-title":"Glucagonomas of transgenic mice express a wide range of general neuroendocrine markers and bioactive peptides","volume":"419","author":"Rindi","year":"1991","journal-title":"Virchows Arch. A Pathol. Anat. Histopathol."},{"key":"10.1016\/j.mce.2015.08.004_bib65","doi-asserted-by":"crossref","first-page":"312","DOI":"10.5732\/cjc.012.10295","article-title":"Pancreatic neuroendocrine tumors: biology, diagnosis, and treatment","volume":"32","author":"Ro","year":"2013","journal-title":"Chin. J. Cancer"},{"key":"10.1016\/j.mce.2015.08.004_bib66","doi-asserted-by":"crossref","first-page":"7039","DOI":"10.1158\/0008-5472.CAN-04-1648","article-title":"Pancreatic insulinomas in multiple endocrine neoplasia, type I knockout mice can develop in the absence of chromosome instability or microsatellite instability","volume":"64","author":"Scacheri","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2015.08.004_bib67","doi-asserted-by":"crossref","first-page":"7358","DOI":"10.1158\/0008-5472.CAN-07-0293","article-title":"Sequential loss of tumor vessel pericytes and endothelial cells after inhibition of platelet-derived growth factor B by selective aptamer AX102","volume":"67","author":"Sennino","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2015.08.004_bib68","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1158\/2159-8290.CD-11-0240","article-title":"Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors","volume":"2","author":"Sennino","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.mce.2015.08.004_bib69","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/MPA.0b013e3181dc67fc","article-title":"Alterations in gene expression in MEN1-associated insulinoma development","volume":"39","author":"Serewko-Auret","year":"2010","journal-title":"Pancreas"},{"key":"10.1016\/j.mce.2015.08.004_bib70","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1158\/0008-5472.CAN-08-3662","article-title":"Recapitulation of pancreatic neuroendocrine tumors in human multiple endocrine neoplasia type I syndrome via Pdx1-directed inactivation of Men1","volume":"69","author":"Shen","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2015.08.004_bib71","doi-asserted-by":"crossref","first-page":"e4897","DOI":"10.1371\/journal.pone.0004897","article-title":"Deciphering von Hippel-Lindau (VHL\/Vhl)-associated pancreatic manifestations by inactivating Vhl in specific pancreatic cell populations","volume":"4","author":"Shen","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.mce.2015.08.004_bib72","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1210\/en.2009-1251","article-title":"Multiple endocrine neoplasia type 1 deletion in pancreatic alpha-cells leads to development of insulinomas in mice","volume":"151","author":"Shen","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2015.08.004_bib73","doi-asserted-by":"crossref","first-page":"19916","DOI":"10.1016\/S0021-9258(17)45460-3","article-title":"Isolation and characterization of renin-expressing cell lines from transgenic mice containing a renin-promoter viral oncogene fusion construct","volume":"265","author":"Sigmund","year":"1990","journal-title":"J.\u00a0Biol. Chem."},{"issue":"5","key":"10.1016\/j.mce.2015.08.004_bib74","doi-asserted-by":"crossref","first-page":"E783","DOI":"10.1210\/jc.2014-4405","article-title":"Glucagon cell hyperplasia and neoplasia with and without glucagon receptor mutations","volume":"100","author":"Sipos","year":"2015","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2015.08.004_bib75","doi-asserted-by":"crossref","first-page":"6637","DOI":"10.1093\/emboj\/20.23.6637","article-title":"Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors","volume":"20","author":"Sotillo","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.mce.2015.08.004_bib76","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.beem.2010.07.003","article-title":"Multiple endocrine neoplasia type 1 (MEN1)","volume":"24","author":"Thakker","year":"2010","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2015.08.004_bib77","first-page":"225","article-title":"Tumorigenesis and eye abnormalities in transgenic mice expressing MSV-SV40 large T-antigen","volume":"5","author":"Theuring","year":"1990","journal-title":"Oncogene"},{"key":"10.1016\/j.mce.2015.08.004_bib78","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.1260825","article-title":"Variation in cancer risk among tissues can be explained by the number of stem cell divisions","volume":"347","author":"Tomasetti","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.mce.2015.08.004_bib79","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/RLU.0b013e3181d6677c","article-title":"Ga-68 DOTATOC PET, endoscopic ultrasonography, and multidetector CT in the diagnosis of duodenopancreatic neuroendocrine tumors: a single-centre retrospective study","volume":"35","author":"Versari","year":"2010","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.mce.2015.08.004_bib80","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ecl.2010.12.010","article-title":"New and emerging syndromes due to neuroendocrine tumors","volume":"40","author":"Vinik","year":"2011","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.mce.2015.08.004_bib81","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ecl.2010.12.008","article-title":"Measuring the relationship of quality of life and health status, including tumor burden, symptoms, and biochemical measures in patients with neuroendocrine tumors","volume":"40","author":"Vinik","year":"2011","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.mce.2015.08.004_bib82","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2337\/diabetes.51.2.398","article-title":"Glucagon replacement via micro-osmotic pump corrects hypoglycemia and alpha-cell hyperplasia in prohormone convertase 2 knockout mice","volume":"51","author":"Webb","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2015.08.004_bib83","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1158\/1078-0432.CCR-11-1102","article-title":"Targeting tumor-associated endothelial cells: anti-VEGFR2 immunoliposomes mediate tumor vessel disruption and inhibit tumor growth","volume":"18","author":"Wicki","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mce.2015.08.004_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2013.02.016","article-title":"PI3K\/Akt\/mTOR pathway inhibitors in the therapy of pancreatic neuroendocrine tumors","volume":"335","author":"Wolin","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.mce.2015.08.004_bib85","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.mce.2015.08.004_bib86","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa1009290","article-title":"RAD001 in advanced neuroendocrine tumors, third trial (RADIANT-3) study group. Everolimus for advanced pancreatic neuroendocrine tumors","volume":"364","author":"Yao","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.mce.2015.08.004_bib87","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/MPA.0b013e31815ceb23","article-title":"Nesidioblastosis and hyperplasia of alpha cells, microglucagonoma, and nonfunctioning islet cell tumor of the pancreas","volume":"36","author":"Yu","year":"2008","journal-title":"Pancreas"},{"key":"10.1016\/j.mce.2015.08.004_bib88","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nrendo.2010.94","article-title":"Radiotherapy: radioactive somatostatin analog therapy against carcinoids","volume":"6","author":"Yu","year":"2010","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.mce.2015.08.004_bib89","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.endonu.2011.04.002","article-title":"A\u00a0natural inactivating mutant of human glucagon receptor exhibits multiple abnormalities in processing and signaling","volume":"58","author":"Yu","year":"2011","journal-title":"Endocrinol. Nutr."},{"key":"10.1016\/j.mce.2015.08.004_bib90","doi-asserted-by":"crossref","first-page":"23397","DOI":"10.1371\/journal.pone.0023397","article-title":"Pancreatic neuroendocrine tumors in glucagon receptor-deficient mice","volume":"6","author":"Yu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.mce.2015.08.004_bib91","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/JME-12-0051","article-title":"Rescue of a pathogenic mutant human glucagon receptor by pharmacological chaperones","volume":"49","author":"Yu","year":"2012","journal-title":"J.\u00a0Mol. Endocrinol."},{"key":"10.1016\/j.mce.2015.08.004_bib92","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.endonu.2012.06.006","article-title":"Glucagon receptor is required for long-term survival: a natural history study of the Mahvash disease in a murine model","volume":"59","author":"Yu","year":"2012","journal-title":"Endocrinol. Nutr."},{"key":"10.1016\/j.mce.2015.08.004_bib93","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/MPA.0b013e3182a5dc77","article-title":"Exocrine pancreas hyperplasia without dysplasia in glucagon receptor knockout mice","volume":"43","author":"Yu","year":"2014","journal-title":"Pancreas"},{"key":"10.1016\/j.mce.2015.08.004_bib94","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1210\/jc.2013-2952","article-title":"Pancreatic \u03b1-cell hyperplasia: facts and myths","volume":"99","author":"Yu","year":"2014","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2015.08.004_bib95","doi-asserted-by":"crossref","first-page":"957","DOI":"10.7150\/ijbs.9773","article-title":"KRAS and DAXX\/ATRX gene mutations are correlated with the clinicopathological features, advanced diseases, and poor prognosis in Chinese patients with pancreatic neuroendocrine tumors","volume":"10","author":"Yuan","year":"2014","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.mce.2015.08.004_bib96","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/MPA.0b013e3181b2bb03","article-title":"Homozygous P86S mutation of the human glucagon receptor is associated with hyperglucagonemia, alpha cell hyperplasia, and islet cell tumor","volume":"38","author":"Zhou","year":"2009","journal-title":"Pancreas"},{"key":"10.1016\/j.mce.2015.08.004_bib97","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1158\/1541-7786.MCR-11-0522","article-title":"Repression of malignant tumor progression upon pharmacologic IGF1R blockade in a mouse model of insulinoma","volume":"10","author":"Zumsteg","year":"2012","journal-title":"Mol. Cancer Res."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720715300447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720715300447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T03:21:09Z","timestamp":1653016869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720715300447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":97,"alternative-id":["S0303720715300447"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2015.08.004","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Animal models of spontaneous pancreatic neuroendocrine tumors","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2015.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}